最近,丙二酸辅酶a脱羧酶(MCD)已被确定为一个关键酶参与了心脏日常的脂肪酸氧化。
Recently, malonyl CoA decarboxylase (MCD) has been identified as a key enzyme involved in the regulation of cardiac fatty acid oxidation.
丙二酸辅酶A脱羧酶(MCD )抑制剂类似的有益效果还体现在受需求诱导的猪在体心脏方面。
Similar beneficial effects of MCD inhibition are seen in the in vivo pig heart subjected to a demand-induced ischemia.
因此,丙二酸辅酶a脱羧酶(MCD)抑制剂代表着一个令人振奋的治疗缺血性心脏病的新靶点。
Hence, inhibition of MCD represents an exciting new target for the treatment of ischemic heart disease.
应用推荐